Striatal Blood–Brain Barrier Permeability in Parkinson'S Disease

Gray, Madison T, Woulfe, John M·2015·Journal of Cerebral Blood Flow & Metabolism
DOI 10.1038/jcbfm.2015.32

Cited by (409)

Items 201–300 of 409

  1. Laminins and the blood-brain barrier
    Ava Nasrollahi, Yao Yao · 2025 · Matrix Biology
  2. Defining Specific Cell States of MPTP-Induced Parkinson’s Disease by Single-Nucleus RNA Sequencing
    Yunxia Guo, Junjie Ma, Hao Huang, Jitao Xu, Chao Jiang, Kaiqiang Ye, Ning Leh Chang, Qinyu Ge, Guang‐Zhong Wang, Xiangwei Zhao · 2022 · International Journal of Molecular Sciences
  3. Human pericytes degrade diverse α-synuclein aggregates
    Birger Victor Dieriks, Blake Highet, Ania Alik, Tracy Bellande, Taylor J. Stevenson, Victoria F. Low, Thomas Park, Jason A. Correia, Patrick M. Schweder, Richard L. M. Faull et al. · 2022 · PLoS ONE
  4. Revealing the mechanisms of blood–brain barrier in chronic neurodegenerative disease: an opportunity for therapeutic intervention
    Sixun Yu, Xin Chen, Tao Yang, Jingmin Cheng, Enyu Liu, Lingli Jiang, Min Song, Haifeng Shu, Yuan Ma · 2024 · Reviews in the Neurosciences
  5. Effect of Coffee against MPTP-Induced Motor Deficits and Neurodegeneration in Mice Via Regulating Gut Microbiota
    Jiaming Liu, Yuhe Zhang, Tao Ye, Qingxia Yu, Jiaheng Yu, Shushu Yuan, Xinxin Gao, Xinxin Wan, Rui Zhang, Weihua Han et al. · 2022 · Journal of Agricultural and Food Chemistry
  6. Aging reduces calreticulin expression and alters spontaneous calcium signals in astrocytic endfeet of the mouse dorsolateral striatum
    Zarate, Sara M., Huntington, Taylor E., Bagher, Pooneh, Srinivasan, Rahul · 2023 · npj Aging
  7. Roles of Non-Coding RNAs as Novel Diagnostic Biomarkers in Parkinson’s Disease
    Ida Manna, Andrea Quattrone, Selene De Benedittis, Enrico Iaccino, Aldo Quattrone · 2021 · Journal of Parkinson s Disease
  8. Cellular mechanisms of fibrin (ogen): insight from neurodegenerative diseases
    Tingting Wen, Zhaohui Zhang · 2023 · Frontiers in Neuroscience
  9. Microvascular blood-brain barrier alterations in isolated brain capillaries of mice over-expressing alpha-synuclein (Thy1-aSyn line 61)
    Kristina Lau, Lisa Teresa Porschen, Franziska Richter, Birthe Gericke · 2023 · Neurobiology of Disease
  10. Molecular Imaging of Striatal Dopaminergic Neuronal Loss and the Neurovascular Unit in Parkinson Disease
    Jana Ivanidze, Myrto Skafida, Sneha Pandya, Dylon Patel, Joseph R. Osborne, Ashish Raj, Ajay Kumar Gupta, Claire Henchcliffe, Jonathan P. Dyke · 2020 · Frontiers in Neuroscience
  11. The Role of Astrocytes and Alpha-Synuclein in Parkinson’s Disease: A Review
    David Brash-Arias, Luis I. García, César Antonio Pérez-Estudillo, Fausto Rojas-Durán, Gonzálo Emiliano Aranda-Abreu, Deissy Herrera‐Covarrubias, Donají Chi-Castañeda · 2024 · NeuroSci
  12. The Breakdown of Neurovascular Barriers: Molecular Mechanisms of Tight Junction Dysfunction
    Sowmya Shree Gopal, Mandeep Kaur, Sophie Lanzkron, Amit K. Srivastava · 2025 · Molecular Neurobiology
  13. A validated quantitative method for the assessment of neuroprotective barrier impairment in neurodegenerative disease models
    Vinod Kumar, John D. Lee, Elizabeth Jane Coulson, Trent M. Woodruff · 2020 · Journal of Neurochemistry
  14. Nanomedicine against Alzheimer’s and Parkinson’s Disease
    Ankit Tandon, Sangh Jyoti Singh, Rajnish Kumar Chaturvedi · 2020 · Current Pharmaceutical Design
  15. Blood–brain barrier permeability in Parkinson’s disease patients with and without dyskinesia
    Koji Fujita, Shichun Peng, Yilong Ma, Chris C. Tang, Matthew Hellman, Andrew Feigin, David Eidelberg, VIJAY M. DHAWAN · 2021 · Journal of Neurology
  16. Inhibition of vascular adhesion protein 1 protects dopamine neurons from the effects of acute inflammation and restores habit learning in the striatum
    Serena Becchi, Alberto Buson, Bernard W. Balleine · 2021 · Journal of Neuroinflammation
  17. Inactivation of microglia dampens blood-brain barrier permeability and loss of dopaminergic neurons in paraquat-lesioned mice
    Yu-Ting Zhou, Ya-Ning Xu, Xiyun Ren, Xiaofeng Zhang · 2023 · Food and Chemical Toxicology
  18. Defining Dysbiosis in Disorders of Movement and Motivation
    Christopher T. Fields, Timothy Robert Sampson, Annadora J. Bruce‐Keller, Drew D. Kiraly, Elaine Y. Hsiao, Geert J. De Vries · 2018 · Journal of Neuroscience
  19. Dissecting the non-neuronal cell contribution to Parkinson’s disease pathogenesis using induced pluripotent stem cells
    Pons-Espinal, Meritxell, Blasco-Agell, Lucas, Consiglio, Antonella · 2021 · Cellular and Molecular Life Sciences
  20. Jia-Jian-Di-Huang-Yin-Zi decoction exerts neuroprotective effects on dopaminergic neurons and their microenvironment
    Jingsi Zhang, Zhennian Zhang, Wen Zhang, Xiangting Li, Ting Wu, Tingting Li, Min Cai, Zhonghai Yu, Jun Yong Xiang, Ding-Fang Cai · 2018 · Scientific Reports
  21. The Zonulin-transgenic mouse displays behavioral alterations ameliorated via depletion of the gut microbiota
    Alba Miranda-Ribera, Gloria Serena, Jundi Liu, Alessio Fasano, Marcy A. Kingsbury, Maria Rosaria Fiorentino · 2021 · Tissue Barriers
  22. Pathological mechanisms of neuroimmune response and multitarget disease-modifying therapies of mesenchymal stem cells in Parkinson’s disease
    Yi Zhuo, Xuan Li, Zhengwen He, Ming Lu · 2023 · Stem Cell Research & Therapy
  23. On-chip modeling of physiological and pathological blood-brain barrier microenvironment for studying glial responses to neuroinflammation
    Yu-Lian Zeng, Yang Du, Xinxin Xu, Yajun Wang, Sai‐Xi Yu, Ting Liu, Shiyuan Luo, Xiaowei Xiang, Wei Liu, Yu-Chen Chen et al. · 2023 · Nano Today
  24. Restoring brain barriers: an innovative approach for treating neurological disorders
    Sighild Lemarchant, Britta Engelhardt, Francesca Cicchetti, Gregory Jaye Bix, Annette Janus, Yann Godfrin, Hélène Blasco, Matthew Campbell, Aurélie de Rus Jacquet · 2025 · Fluids and Barriers of the CNS
  25. The Interface between Inflammatory Bowel Disease, Neuroinflammation, and Neurological Disorders
    Grace E. Hey, Vinata Vedam‐Mai, Matthew Beke, Manuel A. Amaris, Adolfo Ramirez‐Zamora · 2023 · Seminars in Neurology
  26. Features of Plasma Homocysteine, Vitamin B12, and Folate in Parkinson's Disease: An Updated Meta-Analysis
    Yiti Liu, Maoyuan Gou, Xiaoyan Guo · 2023 · Journal of Integrative Neuroscience
  27. Heterogeneity of cellular inflammatory responses in ageing white matter and relationship to Alzheimer’s and small vessel disease pathologies
    Rachel Waller, Ruth Narramore, Julie E. Simpson, Paul Roy Heath, Nikita Verma, Megan Tinsley, Jordan R. Barnes, Hanna T. Haris, Frances E. Henderson, Fiona E. Matthews et al. · 2020 · Brain Pathology
  28. Prasinezumab slows motor progression in Parkinsons disease: beyond the clinical data
    Bin Xiao, Eng‐King Tan · 2025 · npj Parkinson s Disease
  29. Fibrinogen in mice cerebral microvessels induces blood–brain barrier dysregulation with aging via a dynamin-related protein 1–dependent pathway
    Partha Kumar Chandra, Manesh Kumar Panner Selvam, Jorge A. Castorena‐Gonzalez, Ibolya Rutkai, Suresh C. Sikka, Ricardo Mostany, David W. Busija · 2023 · GeroScience
  30. Bifidobacterium pseudocatenulatum NCU-08 ameliorated senescence via modulation of the AMPK/Sirt1 signaling pathway and gut microbiota in mice
    Qingwei Zeng, Zhanghua Qi, Xia He, Chuanlin Luo, Jianing Wen, Jing Wei, Fenfang Yue, Xuanqi Zhao, Hong Wei, Tingtao Chen · 2024 · Food & Function
  31. Multifunctional Nanoparticles for Successful Targeted Drug Delivery across the Blood-Brain Barrier
    Débora Braga Vieira, Lionel Fernel Gamarra · 2018 · InTech eBooks
  32. Treating brain diseases using systemic parenterally-administered protein therapeutics: Dysfunction of the brain barriers and potential strategies
    Ahlem Zaghmi, Janelle Drouin‐Ouellet, Davide Brambilla, Marc Andre Gauthier · 2020 · Biomaterials
  33. Increased YKL-40 but Not C-Reactive Protein Levels in Patients with Alzheimer’s Disease
    Víctor Antonio Blanco-Palmero, Marcos Rubio‐Fernández, Desireé Antequera, Alberto Villarejo‐Galende, José Antonio Pérez-Molina, Isidró Ferrer, Fernando Benito Bartolomé, Eva Carro · 2021 · Biomedicines
  34. The Blood brain-barrier and its role in Alzheimer’s disease
    Steffen E. Storck, Claus U. Pietrzik · 2018 · e-Neuroforum
  35. Detection of Cerebrovascular Loss in the Normal Aging C57BL/6 Mouse Brain Using in vivo Contrast-Enhanced Magnetic Resonance Angiography
    Lindsay K. Hill, Dung Minh Hoang, Luis A. Chiriboga, Thomas Wısnıewskı, Martin J. Sadowski, Youssef Zaim Wadghiri · 2020 · Frontiers in Aging Neuroscience
  36. Human Brain-Based Models Provide a Powerful Tool for the Advancement of Parkinson’s Disease Research and Therapeutic Development
    Sarah F. McComish, Adina N. MacMahon Copas, Maeve A. Caldwell · 2022 · Frontiers in Neuroscience
  37. Do Bacterial Outer Membrane Vesicles Contribute to Chronic Inflammation in Parkinson’s Disease?
    Tiana F. Koukoulis, Leah C. Beauchamp, Maria Kaparakis‐Liaskos, Rachel Mai McQuade, Adityas Purnianto, David Isaac Finkelstein, Kevin Jeffrey Barnham, Laura J. Vella · 2024 · Journal of Parkinson s Disease
  38. Genome-Wide Multiple Sclerosis Association Data and Coagulation
    Sara La Starza, Michela Ferraldeschi, Maria Chiara Buscarinu, Silvia Romano, Arianna Fornasiero, Rosella Mechelli, Renato Umeton, Giovanni Ristori, Marco Salvetti · 2019 · Frontiers in Neurology
  39. First record on mercury accumulation in mice brain living in active volcanic environments: a cytochemical approach
    Alicia Navarro‐Sempere, Yolanda Segovia, Armindo Rodrigues, Patrícia Garcia, Ricardo Camarinho, Magdalena Garcı́a · 2020 · Environmental Geochemistry and Health
  40. TNF-α-NF-κB activation through pathological α-Synuclein disrupts the BBB and exacerbates axonopathy
    Min‐Tae Jeon, Sinnead Anne Cogill, Kyu‐Sung Kim, Yong-Jin Kim, Hye‐Rin Kim, Chung-Yeol Lee, Suji Kim, Suhyeon Son, Jeong-Yeon Kim, Jaehyeok Lee et al. · 2025 · Cell Reports
  41. Intraperitoneal injection of iron dextran induces peripheral iron overload and mild neurodegeneration in the nigrostriatal system in C57BL/6 mice
    Meiyu Liang, Lei Chen, Qing He, Xiaoqing Mi, Le Qu, Junxia Xie, Ning Song · 2023 · Life Sciences
  42. The Contribution of Type 2 Diabetes to Parkinson’s Disease Aetiology
    Samo Ribarič · 2024 · International Journal of Molecular Sciences
  43. Evolving insights into erythrocytes in synucleinopathies.
    Ying Yang, Xiao-Qian Nie, Ya-Jie Wang, Jie Sun, Xiaofei Gao, Jing Zhang · 2024 · Trends in Neurosciences
  44. The Role of Astrocytes in Parkinson’s Disease
    Roger Garcia, Sara M. Zarate, Rahul Srinivasan · 2024 · Advances in neurobiology
  45. The impact of body position on neurofluid dynamics: present insights and advancements in imaging
    Marco Muccio, Zhe Sun, David Chu, Brianna E. Damadian, Lawrence A. Minkoff, Luciano Bonanni, Yulin Ge · 2024 · Frontiers in Aging Neuroscience
  46. Patients with Parkinson’s Disease and Myasthenia Gravis—A Report of Three New Cases and Review of the Literature
    Irina Odajiu, Eugenia Irene Davidescu, Cristina Elena Mitu, Bogdan Ovidiu Popescu · 2019 · Medicina
  47. The Vasomotor Response to Dopamine Is Altered in the Rat Model of l ‐dopa‐Induced Dyskinesia
    Samuel Booth, Abdullah Ramadan, Dali Zhang, Lingling Lu, Gilbert J. Kirouac, Michael F. Jackson, Christopher M. Anderson, Ji Hyun Ko · 2020 · Movement Disorders
  48. A critical role for GM1 ganglioside in the pathophysiology and potential treatment of Parkinson’s disease
    Jay S. Schneider · 2021 · Glycoconjugate Journal
  49. Gut microbiota and inflammation in Parkinson’s disease: Pathogenetic and therapeutic insights
    Tong Guo, Li Chen · 2022 · European Journal of Inflammation
  50. The Therapeutic Benefits of Intravenously Administrated Nanoparticles in Stroke and Age-related Neurodegenerative Diseases
    Mehdi Farhoudi, Saeed Sadigh‐Eteghad, Javad Mahmoudi, Afsaneh Farjami, Mohammad Mahmoudian, Sara Salatin · 2022 · Current Pharmaceutical Design
  51. Extraintestinal manifestations of inflammatory bowel disease, nitroxidative stress and dysbiosis: What is the link between them?
    Amylly Sanuelly da Paz Martins, Samara Bomfim Gomes Campos, Marília Oliveira Fonseca Goulart, Fabiana, Fabiana Andréa Moura · 2021 · Biocell
  52. Mitochondrial Changes in Rat Brain Endothelial Cells Associated with Hepatic Encephalopathy: Relation to the Blood–Brain Barrier Dysfunction
    Krzysztof Milewski, Karolina Orzeł-Gajowik, Magdalena Zielińska · 2022 · Neurochemical Research
  53. GM1 Ganglioside as a Disease-Modifying Therapeutic for Parkinson’s Disease: A Multi-Functional Glycosphingolipid That Targets Multiple Parkinson’s Disease-Relevant Pathogenic Mechanisms
    Jay S. Schneider · 2023 · International Journal of Molecular Sciences
  54. The Common Denominators of Parkinson’s Disease Pathogenesis and Methamphetamine Abuse
    Bruno Vincent, Mayuri Shukla · 2023 · Current Neuropharmacology
  55. Erythrocyte-derived extracellular vesicles transcytose across the blood-brain barrier to induce Parkinson’s disease-like neurodegeneration
    Hélèna L. Denis, Aurélie de Rus Jacquet, Melanie Alpaugh, Michel Panisset, Roger A. Barker, Éric Boilard, Francesca Cicchetti · 2025 · Fluids and Barriers of the CNS
  56. Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson’s Disease
    Pranay Srivastava, Shuhei Nishiyama, Fang Zhou, Sonia Lin, Akriti Srivastava, Chien‐Wen Su, Yuehang Xu, Weiyi Peng, Michael Levy, Michael A. Schwarzschild et al. · 2023 · Journal of Neuroimmune Pharmacology
  57. Astrocytes, a Promising Opportunity to Control the Progress of Parkinson’s Disease
    Alberto Sánchez, Ingrid Moráles, Clara Rodriguez‐Sabate, Miguel Solé-Sabater, Manuel Rodrı́guez · 2021 · Biomedicines
  58. Interleukin 13 on Microglia is Neurotoxic in Lipopolysaccharide-injected Striatumin vivo
    Ah Reum Hong, Jae Geun Jang, Young Cheul Chung, So-Yoon Won, Byung Kwan Jin · 2022 · Experimental Neurobiology
  59. Dopamine Agonist Cotreatment Alters Neuroplasticity and Pharmacology of Levodopa ‐Induced Dyskinesia
    Elena Espa, Lu Song, Katrine Skovgård, Silvia Fanni, Maria Angela Cenci · 2023 · Movement Disorders
  60. Blood–Brain Barrier Breakdown in Stress and Neurodegeneration: Biochemical Mechanisms and New Models for Translational Research
    Alla B. Salmina, Yulia K. Komleva, Nataliya A. Malinovskaya, Andrey V. Morgun, Елена Анатольевна Тепляшина, Olga L. Lopatina, Yana V. Gorina, Ekaterina Viktorovna Kharitonova, Е. Д. Хилажева, Аnton N. Shuvaev · 2021 · Biochemistry (Moscow)
  61. Impaired tissue barriers as potential therapeutic targets for Parkinson’s disease and amyotrophic lateral sclerosis
    Xin Fang · 2018 · Metabolic Brain Disease
  62. 5-HT1F receptor agonism induces mitochondrial biogenesis and increases cellular function in brain microvascular endothelial cells
    Natalie E. Scholpa, Epiphani C. Simmons, Austin D. Thompson, Seth S. Carroll, Rick G. Schnellmann · 2024 · Frontiers in Cellular Neuroscience
  63. Sleep Disturbance in Parkinson’s Disease: Consequences for the Brain and Disease Progression – A Narrative Review
    Kirstie N. Anderson, Michael John Keogh, Luca Gosse · 2025 · Nature and Science of Sleep
  64. Involvement of an Aberrant Vascular System in Neurodevelopmental, Neuropsychiatric, and Neuro-Degenerative Diseases
    Keiichi Ishihara, Kazuyuki Takata, Ken‐ichi Mizutani · 2023 · Life
  65. Influence of focused ultrasound on locoregional drug delivery to the brain: Potential implications for brain tumor therapy
    Rafael Uribe-Cardenas, Madeline Laramee, Ishani Ray, Nadia Dahmane, Mark S. Souweidane, Brice Martin · 2023 · Journal of Controlled Release
  66. Blood–brain barrier dysfunction in multiple system atrophy: A human postmortem study
    Ramil Gabdulkhaev, Hiroshi Shimizu, Masato Kanazawa, Yasuko Kuroha, Arika Hasegawa, Jiro Idezuka, Kazuki Tainaka, Osamu Onodera, Akiyoshi Kakita · 2024 · Neuropathology
  67. Bezafibrate improves mitochondrial function, blood-brain barrier integrity, and social deficits in models of 22q11.2 deletion syndrome
    Alexis Mary Crockett, Maria C. Vélez Colόn, Hania Kébir, Frances M. Smith, Daniel Maxim Iascone, Brianna Ciesielski, С. А. Кошкин, Andrew D. Patterson, Adam J. Rossano, Amita Sehgal et al. · 2025 · Science Translational Medicine
  68. Sex- and age- differences in the expression of critical blood-brain barrier regulators: a physiological context
    Xue Mi, Zi-Ling Ye, Xujun Zhang, Xiaochun Chen, Xiaoman Dai · 2025 · Biology of Sex Differences
  69. Iron distribution in the lentiform nucleus: A post-mortem MRI and histology study
    Amaury De Barros, Germain Arribarat, Jean Albert Lotterie, Gaëlle Dominguez, Patrick Chaynes, Patrice Péran · 2021 · Brain Structure and Function
  70. Acupuncture modulates the microbiota-gut-brain axis: a new strategy for Parkinson’s disease treatment
    Zimo Zang, Fang Yang, Liang Qu, Minghui Ge, Liang Tong, Lihui Xue, Xiuye Sun, Ying Hai · 2025 · Frontiers in Aging Neuroscience
  71. Para-Cresol and the Brain: Emerging Role in Neurodevelopmental and Neurodegenerative Disorders and Therapeutic Perspectives
    Laura Bertarini, Federico Imbeni, Virginia Brighenti, Isabella Martusciello, Federica Pellati, Silvia Alboni · 2025 · ACS Pharmacology & Translational Science
  72. Micro-nanoplastics and Parkinson’s disease: evidence and perspectives
    Lu Lin, Jin Li, Si Zhu, Zhiling Zhang, Zhigang Li, Pingyi Xu, Wenyuan Guo · 2026 · npj Parkinson s Disease
  73. The 3D Brain Unit Network Model to Study Spatial Brain Drug Exposure under Healthy and Pathological Conditions
    Esmée Vendel, Vivi Rottschäfer, Elizabeth C. M. de Lange · 2020 · Pharmaceutical Research
  74. 慢性牙周炎与帕金森病相关性的研究进展
    Mengyao Bian, Lili Chen, Lihong Lei · 2022 · Journal of Zhejiang University (Medical Sciences)
  75. Unravelling the genetic links between Parkinson’s disease and lung cancer
    Yong Qi Leong, Rhun Yian Koh, Soi Moi Chye, Khuen Yen Ng · 2023 · Biological Chemistry
  76. Unraveling the link between neuropathy target esterase NTE/SWS, lysosomal storage diseases, inflammation, abnormal fatty acid metabolism, and leaky brain barrier
    Tsap, Mariana I, Yatsenko, Andriy S, Hegermann, Jan, Beckmann, Bibiana, Tsikas, Dimitrios, Shcherbata, Halyna R · 2024 · eLife
  77. Pharmacological Intervention Targeting FAF1 Restores Autophagic Flux for α-Synuclein Degradation in the Brain of a Parkinson’s Disease Mouse Model
    Bok‐Seok Kim, Jin-A Song, Ki-Hong Jang, Taeik Jang, Bumjun Jung, Sung‐Eun Yoo, Jae Moon Lee, Eunhee Kim · 2022 · ACS Chemical Neuroscience
  78. Biorobotic Drug Delivery for Biomedical Applications
    Quoc‐Viet Le, Gayong Shim · 2024 · Molecules
  79. Pericyte derivation and transplantation for blood-CNS barrier reconstitution in CNS disorders
    Hyun‐Woo Kim, Kenneth Lap‐Kei Wu, Kin-Wai Tam, YS Chan, Daisy Kwok‐Yan Shum · 2024 · IBRO Neuroscience Reports
  80. Improving measurement of blood-brain barrier permeability with reduced scan time using deep-learning-derived capillary input function
    Jonghyun Bae, Chenyang Li, Arjun V. Masurkar, Yulin Ge, Sungheon Kim · 2023 · NeuroImage
  81. Role of Cellular Senescence in Parkinson’s Disease: Potential for Disease-Modification Through Senotherapy
    David J. Rademacher, Jacob E. Exline, Eileen M. Foecking · 2025 · Biomedicines
  82. The intersection of circadian rhythms and the blood-brain barrier with drug efficacy and delivery in neurological disorders
    Kyra A. Schindler, Silvia Torices, Nicolette Ann Schurhoff, Daniela Iglesias Gallo, Michal J. Toborek · 2025 · Advanced Drug Delivery Reviews
  83. Dysregulated Coagulation in Parkinson’s Disease
    X. Wang, Wenxin Li, Xinyue Zhao, Ning Hu, Xi Wang, Xilin Xiao, Kai Yang, Taolei Sun · 2024 · Cells
  84. Chronic exposure to volcanic gaseous elemental mercury: using wild Mus musculus to unveil its uptake and fate
    Ricardo Camarinho, Alicia Navarro‐Sempere, Patrícia Garcia, Magdalena Garcı́a, Yolanda Segovia, Armindo Rodrigues · 2021 · Environmental Geochemistry and Health
  85. Translational control in neurovascular brain development
    Kleanthi Chalkiadaki, Elpida Statoulla, Μαρία Μάρκου, Sofia Bellou, Eleni Bagli, Theodore Fotsis, Carol Murphy, Christos G. Gkogkas · 2021 · Royal Society Open Science
  86. ATAXIA TELANGIECTASIA MUTATED PROTECTS AGAINST LIPOPOLYSACCARIDE-INDUCED BLOOD-BRAIN BARRIER DISRUPTION BY REGULATING ATK/DRP1-MEDIATED MITOCHONDRIAL HOMEOSTASIS
    Shiyuan Luo, Zhuochen Lyu, Lingling Ge, Yinjiao Li, Yuqi Liu, Yuan Yuan, Rui Zhao, Lei Huang, Jian‐Yuan Zhao, Hongjun Huang et al. · 2023 · Shock
  87. Biointeraction of Erythrocyte Ghost Membranes with Gold Nanoparticles Fluorescents
    Víctor Gómez Flores, Alejandro Martı́nez-Martı́nez, Jorge A. Roacho-Pérez, Jazzely Acosta Bezada, Francisco Servando Aguirre-Tostado, Perla E. García‐Casillas · 2021 · Materials
  88. Central and Peripheral Immunity Responses in Parkinson’s Disease: An Overview and Update
    Ghaidaa Ebrahim, Hunter J. Hutchinson, Melanie Gonzalez, Abeer Dagra · 2025 · Neuroglia
  89. Red Blood Cells in Health and Disease
    Aradhya Giri, Sandhya Tamgadge · 2024 · Journal of Microscopy and Ultrastructure
  90. Pathology-directed drug delivery strategies: How to overcome blood–brain barrier for the treatment of brain diseases
    Yun Chen, Xinzhu Sun, Yilong Xi, Zhenyu Luo, Huarong Lai, Dongxin Zhu, Yifan Zhang, Feng Xu, Jian Li, Jianping Zhou et al. · 2025 · Acta Pharmaceutica Sinica B
  91. Neurodegenerative Etiology of Aromatic L-Amino Acid Decarboxylase Deficiency: a Novel Concept for Expanding Treatment Strategies
    Zohara Sternberg · 2023 · Molecular Neurobiology
  92. Trends and hotspots on the relationship between gut microbiota and Parkinson’s Disease: a bibliometric analysis
    Xuefeng Li, Xiaogang Hao, Chunhai Chen, Chao Zhai, Ting Pan, Xue Zhou, Yang Liu, Dalong Wu, Xinhua Chen · 2024 · Frontiers in Cellular and Infection Microbiology
  93. From blood vessels to brain cells: Connecting the circulatory system and Parkinson's disease
    Oyedele J. Olaoye, Sophie L. Farrow, Denis M. Nyaga, Antony A. Cooper, Justin Martin O'Sullivan · 2025 · Journal of Parkinson s Disease
  94. Impaired neuronal activity as a potential factor contributing to the underdeveloped cerebrovasculature in a young Parkinson’s disease mouse model
    Jin-Young Jeong, Hyun Jung Lee, Namsuk Kim, Yan Li, Jong‐Cheol Rah, Won‐Jong Oh · 2023 · Scientific Reports
  95. Elucidating cortical neurovascular involvement in Huntington's disease using human brain tissue microarrays
    Adelie Y. S. Tan, Lance C M G Martinez, Helen C. Murray, Nasim F. Mehrabi, Lynette J. Tippett, Clinton P. Turner, Maurice A. Curtis, Richard L. M. Faull, Mike Dragunow, Malvindar K. Singh‐Bains · 2025 · Neurobiology of Disease
  96. Immunotherapeutic interventions in Parkinson's disease: Focus on α-Synuclein
    Upasana Ganguly, Sukhpal Singh, Sasanka Chakrabarti, Adesh Kumar Saini, Reena Vohra Saini · 2022 · Advances in protein chemistry and structural biology
  97. Targeting Cerebrovascular Impairments in Huntington’s Disease: A Novel Treatment Perspective
    Isabelle St‐Amour, Benoît Aubé, Marie Rieux, Francesca Cicchetti · 2015 · Neurodegenerative Disease Management
  98. Blood-Brain Barrier Dysfunction in the Detrimental Brain Function
    Alejandro González‐Candia, Nicole K. Rogers, Rodrigo L. Castillo · 2021 · IntechOpen eBooks
  99. Angiogenesis
    David G. Muñoz, John Woulfe · 2015 · Neurology
  100. References
    Christopher A. Shaw · 2017 · Wiley eBooks